What are the treatment options for myeloproliferative neoplasms?

Myeloproliferative neoplasms are a group of disorders in which the bone marrow makes too many or abnormal blood cells. The exact plan depends on whether red cells, platelets or white cells are most affected, along with symptoms, clotting history, bleeding risk and changes over time. Some people need regular review and blood tests before treatment is started.

Medicines may lower excess cell production or reduce clotting risk when appropriate. Targeted therapy acts on selected disease pathways and may help control symptoms or blood counts. Blood transfusion support can be used when low red-cell levels or other treatment effects cause clinically significant problems.

Bring a list of medicines and supplements to each appointment, and report headaches, vision changes, chest discomfort, new limb swelling, unusual bleeding or worsening fatigue. Ask how often blood counts are needed and which symptoms require urgent review. Learn more about [Targeted Therapy](/treatments/systemic-therapy/targeted-therapy/) and [Blood Transfusion Support](/treatments/cellular-and-transplant-therapy/blood-transfusion-support/).

Seek urgent medical help for sudden weakness on one side, trouble speaking, severe chest pain, severe breathlessness, a painful swollen limb, coughing blood or bleeding that will not stop. These can signal a clot or bleeding problem and should not wait for a routine appointment.

Which type of myeloproliferative neoplasm do I have? Is the aim to control cell counts, symptoms or clotting risk? What monitoring schedule do I need? Could transfusion support or targeted therapy be relevant to my situation?